(Q35098581)

6 August 2017

title

In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803) (English)

1 reference

6 August 2017

Erika Marzola

9

0 references

Jonathan P. Thompson

Jonathan P Thompson

6

0 references

Severo Salvadori

Severo Salvadori

10

0 references

Remo Guerrini

Remo Guerrini

8

0 references

David G Lambert

David G Lambert

14

0 references

Domenico Regoli

12

Domenico Regoli

1 reference

6 August 2017

Valeria Camarda

1

1 reference

6 August 2017

Martina Spagnol

2

1 reference

6 August 2017

Wei Song

3

1 reference

6 August 2017

Raffaella Vergura

4

1 reference

6 August 2017

Adelheid L Roth

5

1 reference

6 August 2017

David J Rowbotham

7

1 reference

6 August 2017

Paolo Cavanni

11

1 reference

6 August 2017

Stephen A Douglas

13

1 reference

6 August 2017

Girolamo Calò

15

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

British Journal of Pharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

147

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

92-100

1 reference

Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Urotensin II stimulates plasma extravasation in mice via UT receptor activation.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Quantitative studies of antagonists for 5-hydroxytryptamine

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

A new ligand for the urotensin II receptor

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Urotensin II evokes potent vasoconstriction in humans in vivo

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Central effects of urotensin-II following ICV administration in rats

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

A new generation of Ca2+ indicators with greatly improved fluorescence properties

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Increased plasma urotensin II levels in patients with diabetes mellitus

9 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0706438

Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Congestive heart failure and expression of myocardial urotensin II.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Structure-activity relationship study on human urotensin II

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615843

Role of urotensin II in patients on dialysis

16 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16273120

12 December 2020

inferred from PubMed ID database lookup

Contraction of major artery segments of rat by fish neuropeptide urotensin II

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16273120

12 December 2020

inferred from PubMed ID database lookup

Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16273120

12 December 2020

inferred from PubMed ID database lookup

Measurement of [Ca2+]i in whole cell suspensions using fura-2.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0706438

7 January 2021

inferred from DOI database lookup

Fluorescent measurement of [Ca2+]c. Basic practical considerations

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0706438

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJP.0706438

1 reference

6 August 2017

1 reference

6 August 2017

1 reference